Aytu Biopharma (AYTU) Debt Ratio (2011 - 2026)

Aytu Biopharma (AYTU) has 15 years of Debt Ratio data on file, last reported at 0.1 in Q1 2026.

• On a quarterly basis, Debt Ratio rose 11.34% year-over-year to 0.1 in Q1 2026; TTM through Mar 2026 was 0.1, a 11.34% increase from a year earlier, with the FY2025 full-year figure at 0.16, up 43.01% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.1, down from 0.16 in the prior quarter.
• Over the last five years, Debt Ratio for AYTU reached as high as 0.16 in Q2 2025 and fell as low as 0.01 in Q1 2024.
• Historically, Debt Ratio has averaged 0.11 across 5 years, with a median of 0.11 in 2023.
• On a YoY basis, Debt Ratio climbed as much as 1633.41% in 2022 and fell as far as 99.92% in 2022.
• Year by year, Debt Ratio stood at 0.1 in 2022, then rose by 17.94% to 0.12 in 2023, then decreased by 16.46% to 0.1 in 2024, then jumped by 53.47% to 0.16 in 2025, then slumped by 34.68% to 0.1 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.1 in Q1 2026, 0.16 in Q4 2025, and 0.1 in Q3 2025.